News

Understanding who is using the latest nicotine product – oral nicotine pouches – is the key to developing future research on the pouches' effects.

Anthony Cannella has always been willing to try the newest treatments for lymphoma. So he readily agreed to sign up for a CAR-T clinical trial at Hollings.

Children who do not meet inclusion criteria for current peds studies now have a chance through an innovative program.

MUSC study shows that long-acting antiretroviral therapy for persons living with HIV can be administered safely and effectively at home.

The Moodivate app improved depression symptoms significantly more than usual care treatment in a clinical trial at 22 MUSC Health primary care practices.

Dr. Jennifer Dahne's focus on making behavioral health interventions accessible to more people has been recognized with a governor's award.

Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.

The cochlear implant team at MUSC Health adds a new clinical trial that’s testing a device that may reduce hearing loss that can happen as an implant goes in.

MUSC Hollings Cancer Center researchers will test whether e-cigarettes are a viable quit smoking option for people who decline other options.

“There's an incredible amount of excitement about this device.” MUSC prepares to place totally under-the-skin cochlear implants in patients with hearing loss.